ホーム>>Signaling Pathways>> GPCR/G protein>> Ras>>RAS inhibitor Abd-7

RAS inhibitor Abd-7

カタログ番号GC62421

強力な RAS 結合化合物 (Kd = 51 nM) である RAS 阻害剤 Abd-7 は、RAS エフェクタータンパク質間相互作用 (PPI) 阻害剤です。 RAS 阻害剤 Abd-7 は、細胞内で RAS と相互作用し、RAS エフェクター相互作用を防ぎ、内因性の RAS 依存性シグナル伝達を阻害します。 RAS 阻害剤 Abd-7 は、PI3K、CRAF、RALGDS、および NRAS Q61H と HRAS G12V によって、さまざまな変異型 KRAS タンパク質の PPI を阻害します。

Products are for research use only. Not for human use. We do not sell to patients.

RAS inhibitor Abd-7 化学構造

Cas No.: 2351843-48-4

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$347.00
在庫あり
5 mg
$315.00
在庫あり
10 mg
$495.00
在庫あり
25 mg
$855.00
在庫あり
50 mg
$1,305.00
在庫あり
100 mg
$2,025.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

RAS inhibitor Abd-7, a potent RAS-binding compound (Kd=51 nM), is a RAS-effector protein-protein interaction (PPI) inhibitor. RAS inhibitor Abd-7 interacts with RAS inside the cells, prevents RAS-effector interactions and inhibits endogenous RAS-dependent signaling. RAS inhibitor Abd-7 impairs the PPI of various mutant KRAS proteins with PI3K, CRAF and RALGDS as well as NRAS Q61H and HRAS G12V[1].

RAS inhibitor Abd-7 (0-20 μM; 24-48 hours) is a cell-potent inhibitor affecting the viability of cancer cell lines in a single digit to low micromolar range[1].

[1]. Quevedo CE, et al. Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment. Nat Commun. 2018;9(1):3169. Published 2018 Aug 9.

レビュー

Review for RAS inhibitor Abd-7

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for RAS inhibitor Abd-7

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.